Atherosclerosis and Vascular Injury: The Effect of a Perivascular Nitric Oxide Donor in a Cholesterol-Fed Rabbit Model

Annals of Vascular Surgery

Volumn 23, Issue 3, 2009, Pages 392-397

  Abbasi, Kyomars ^a   Anvari, Maryam Sotudeh ^a   Mahdanian, Abolfazl ^a   Ahmadi, Seyed Hosein ^a   Rabbani, Shahram ^a   Karimi, Abbasali ^a   Marzban, Mehrab ^a   Shalileh, Keivan ^a   Ashrafinia, Narges ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLENETRIAMINE; DIETHYLENETRIAMINE NITRIC OXIDE DONOR; ELASTOMER; NITRIC OXIDE DONOR; SILASTIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BLOOD; BLOOD VESSEL INJURY; CHOLESTEROL DIET; CONTROLLED STUDY; EXPERIMENTAL RABBIT; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AORTA; ATHEROSCLEROSIS; BALLOON DILATATION; CHOLESTEROL, DIETARY; DIMETHYLPOLYSILOXANES; DISEASE MODELS, ANIMAL; DOSAGE FORMS; DRUG CARRIERS; HYPERCHOLESTEROLEMIA; MALE; NITRIC OXIDE DONORS; RABBITS; SEVERITY OF ILLNESS INDEX; TRIAZENES;

EID: 67349203830     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2008.11.003     Document Type: Article

References (33)

1. Harnek J., Zoucas E., Sjuve R., et al. Local infusion of the nitric oxide donor Sin-1 after angioplasty. Effects on intimal hyperplasia in porcine coronary arteries. Acta Radiol 44 (2003) 395-402
2. Kiernan T.J., Yan B.P., Cruz-Gonzalez I., et al. Pharmacological and cellular therapies to prevent restenosis after percutaneous transluminal angioplasty and stenting. Cardiovasc Hematol Agents Med Chem 6 (2008) 116-124
3. Xavier D., Pais P., Devereaux P.J., et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 371 9622 (2008) 1435-1442
4. Rodés-Cabau J., Facta A., Larose E., et al. Predictors of aorto-saphenous vein bypass narrowing late after coronary artery bypass grafting. Am J Cardiol 100 (2007) 640-645
5. Gruntzig A.R., Senning A., and Siegenthaler W.E. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 301 (1979) 61-68
6. Fitzgibbon G.M., Kafka H.O., Keach A.J., et al. Coronary bypass graft fate and patient outcome; angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28 (1996) 616-626
7. Barner H.B., and Barnett M.B. Fifteen to twenty-one-year angiographic assessment of internal thoracic artery as a bypass conduit. Ann Thorac Surg 56 (1994) 1526-1528
8. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43 (1991) 109-142
9. Knowles J.W., Reddick R.L., Jennette J.C., et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest 105 (2000) 451-458
10. Kuhlencordt P.J., Gyurko R., Han F., et al. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 104 (2001) 448-454
11. Yogo K., Shimokawa H., Funakoshi H., et al. Different vasculoprotective roles of NO synthase isoforms in vascular lesion formation in mice. Arterioscler Thromb Vasc Biol 20 (2000) E96-E100
12. Kurose I., Wolf R., Cerwinka W., et al. Microvascular responses to ischemia/reperfusion in normotensive and hypertensive rats. Hypertension 34 (1999) 212-216
13. Prior J.T., Kurtz D.M., and Zeigler D.D. The hypercholesterolemic rabbit. Arch Pathol 71 (1961) 672-684
14. LeVeen R.F., Wolf G.L., and Villanueva T.G. New rabbit atherosclerosis model for the investigation of transluminal angioplasty. Invest Radiol 17 (1982) 470-475
15. Dow Corning. Silastic MDX4-4210 biomedical grade elastomer with catalyst [online]. 2008 [9 Nov 2008] Available from: URL: http://www.dowcorning.com/applications/search/products/details.aspx?prod=01295284&;type=PROD.
16. Kitamoto S., Egashira K., and Takeshita A. Stress and vascular responses: Anti-inflammatory therapeutic strategy against atherosclerosis and restenosis after coronary intervention. J Pharmacol Sci 91 (2003) 192-196
17. Moreno P.R., Palacios I.F., Leon M.N., et al. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue. Am J Cardiol 84 (1999) 462-466 A9
18. Moncada S., and Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 329 (1993) 2002-2012
19. Zhang L.N., da Cunha V., Martin-McNulty B., et al. Endothelial nitric oxide synthase deficiency enhanced carotid artery ligation-induced remodeling by promoting vascular inflammation. J Appl Res 6 (2006) 100-113
20. Gauthier T.W., Scalia R., Murohara T., et al. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol 15 (1995) 1652-1659
21. De Caterina R., Libby P., Peng H.B., et al. Nitric oxide decreases cytokine induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96 (1995) 60-68
22. Cornwell T.L., Arnold E., Boerth N.J., et al. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP dependent protein kinase by cGMP. Am J Physiol 267 5 Pt 1 (1994) C1405-C1413
23. Dubey R.K., Jackson E.K., and Luscher T.F. Nitric oxide inhibits angiotensin II induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest 96 (1995) 141-149
24. Kapadia M.R., Chow L.W., Tsihlis N.D., et al. Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia. J Vasc Surg 47 (2008) 173-182
25. Yamamoto T., and Bing R.J. Nitric oxide donors. Proc Soc Exp Biol Med 225 (2000) 200-206
26. Balbatun A., Louka F.R., and Malinski T. Dynamics of nitric oxide release in the cardiovascular system. Acta Biochim Pol 50 (2003) 61-68
27. Huk I., Nanobashvili J., Neumayer C., et al. l-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96 (1997) 667-675
28. Gryglewski R.J., Palmer R.M., and Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320 6061 (1986) 454-456
29. Dusting G.J., Fennessy P., Yin Z.L., et al. Nitric oxide in atherosclerosis: vascular protector or villain. Clin Exp Pharmacol Physiol Suppl 25 (1998) S34-S41
30. Brune B., Sandau K., and Knethen A. Apoptotic cell death and nitric oxide: activating and antagonistic transducing pathways. Biochemistry (Mosc) 63 (1998) 817-825
31. Lablanche J.M., Grollier G., Lusson J.R., et al. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD study. Circulation 95 (1997) 83-89
32. Narayanaswamy M., Wright K.C., and Kandarpa K. Animal models for atherosclerosis, restenosis, and endovascular graft research. J Vasc Interv Radiol 11 (2000) 5-17
33. Ahmad-Raus R.R., Abdul-Latif E.S., and Mohammad J.J. Lowering of lipid composition in aorta of guinea pigs by Curcuma domestica. BMC Complement Altern Med 1 (2001) 6